OBJECTIVE: Relapse is a major problem in drug addiction treatment. Both drug craving and drug-related cognitions (e.g., attentional bias and implicit attitudes to drugs) may contribute to relapse. Using ecological momentary assessments, we examined whether craving and cognitions assessed during drug detoxification treatment were associated with relapse. METHOD: Participants were 68 heroin-dependent inpatients undergoing clinical detoxification at an addiction treatment center. Participants carried around a personal digital assistant for 1 week. Participants completed up to 4 random assessments (RAs) per day. They also completed an assessment when they experienced a temptation to use drugs (TA). At each assessment, participants reported their craving and attitudes to drugs. Implicit cognitions were assessed with a drug Stroop task (attentional bias) and an Implicit Association Test (implicit attitudes). RESULTS: Individuals who relapsed during the study week exhibited a larger attentional bias and more positive implicit attitudes to drugs than did nonrelapsers at TAs (but not RAs). In addition, compared to nonrelapsers, relapsers reported higher levels of craving and more positive explicit attitudes to drugs at TAs than at RAs. Additional within-subject analyses revealed that attentional bias for drugs at TAs increased before relapse. CONCLUSIONS: Drug-related cognitive processes assessed with ecological momentary assessments were associated with relapse during drug detoxification. Real-time assessment of craving and cognitions may help to identify which individuals are at risk of relapse and when they are at risk of relapse.
OBJECTIVE: Relapse is a major problem in drug addiction treatment. Both drug craving and drug-related cognitions (e.g., attentional bias and implicit attitudes to drugs) may contribute to relapse. Using ecological momentary assessments, we examined whether craving and cognitions assessed during drug detoxification treatment were associated with relapse. METHOD:Participants were 68 heroin-dependent inpatients undergoing clinical detoxification at an addiction treatment center. Participants carried around a personal digital assistant for 1 week. Participants completed up to 4 random assessments (RAs) per day. They also completed an assessment when they experienced a temptation to use drugs (TA). At each assessment, participants reported their craving and attitudes to drugs. Implicit cognitions were assessed with a drug Stroop task (attentional bias) and an Implicit Association Test (implicit attitudes). RESULTS: Individuals who relapsed during the study week exhibited a larger attentional bias and more positive implicit attitudes to drugs than did nonrelapsers at TAs (but not RAs). In addition, compared to nonrelapsers, relapsers reported higher levels of craving and more positive explicit attitudes to drugs at TAs than at RAs. Additional within-subject analyses revealed that attentional bias for drugs at TAs increased before relapse. CONCLUSIONS: Drug-related cognitive processes assessed with ecological momentary assessments were associated with relapse during drug detoxification. Real-time assessment of craving and cognitions may help to identify which individuals are at risk of relapse and when they are at risk of relapse.
Authors: Susan L Ames; Jerry L Grenard; Carolien Thush; Steve Sussman; Reinout W Wiers; Alan W Stacy Journal: Exp Clin Psychopharmacol Date: 2007-04 Impact factor: 3.157
Authors: Marlies A E Marissen; Ingmar H A Franken; Andrew J Waters; Peter Blanken; Wim van den Brink; Vincent M Hendriks Journal: Addiction Date: 2006-09 Impact factor: 6.526
Authors: Christopher S Stauffer; Vivek Musinipally; Angela Suen; Kara L Lynch; Brad Shapiro; Joshua D Woolley Journal: Addict Res Theory Date: 2016-05-25
Authors: Reshmi Marhe; Maartje Luijten; Ben J M van de Wetering; Marion Smits; Ingmar H A Franken Journal: Neuropsychopharmacology Date: 2013-01-07 Impact factor: 7.853
Authors: Adriaan Spruyt; Valentine Lemaigre; Bihiyga Salhi; Dinska Van Gucht; Helen Tibboel; Bram Van Bockstaele; Jan De Houwer; Jan Van Meerbeeck; Kristiaan Nackaerts Journal: Psychopharmacology (Berl) Date: 2015-03-13 Impact factor: 4.530
Authors: Josh D Woolley; Peter A Arcuni; Christopher S Stauffer; Daniel Fulford; Dean S Carson; Steve Batki; Sophia Vinogradov Journal: Psychopharmacology (Berl) Date: 2016-05-03 Impact factor: 4.530